$ cat ./records/gates-foundation-awards-11-million-to-international-consortium-to-2014.txt
Gates Foundation Awards $11 Million to International Consortium to Develop East Coast Fever Vaccine
[RECORD.TXT] · cat --full
The Bill & Melinda Gates Foundation funded an $11 million grant to an ILRI-led international consortium to develop a new or improved vaccine against East Coast fever (ECF) — a tick-transmitted disease caused by the parasite Theileria parva that kills one million cattle per year across 11 East and Central African countries, causing $300 million in annual losses. The consortium included ILRI, GALVmed, USDA-ARS, the Roslin Institute, Washington State University, and the Centre for Ticks and Tick-Borne Diseases in Malawi. The existing live vaccine required cold-chain management; the project aimed to develop a safer, more stable, and cost-effective alternative.
Source: https://phys.org/news/2014-01-scientists-multi-million-dollar-african-disease.html
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Funds GALVmed Babesiosis Vaccine Research to Combat Tick-Borne Cattle Disease Across Africa
Next →
Gates Foundation Donates to MIT Media Lab During Period of Epstein Funding
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.